UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054593
Receipt number R000062381
Scientific Title Investigation on complications caused by barium/foaming agents after upper gastrointestinal X-ray examination
Date of disclosure of the study information 2024/07/01
Last modified on 2024/06/06 16:38:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation on complications caused by barium/foaming agents after upper gastrointestinal X-ray examination

Acronym

Investigation on complications caused by barium/foaming agents after upper gastrointestinal X-ray examination

Scientific Title

Investigation on complications caused by barium/foaming agents after upper gastrointestinal X-ray examination

Scientific Title:Acronym

Investigation on complications caused by barium/foaming agents after upper gastrointestinal X-ray examination

Region

Japan


Condition

Condition

complications caused by barium/foaming agents after upper gastrointestinal X-ray examination

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In upper gastrointestinal X-ray examinations, a foaming agent is taken immediately before the examination to inflate the stomach with carbon dioxide gas, and the examination is performed using a barium contrast agent. Studies conducted by academic societies and other organizations have revealed the occurrence of accidental symptoms caused by the use of foaming agents and barium contrast agents during examinations, but it is not possible to ascertain the occurrence of accidental symptoms and the severity of symptoms that occur after patients return home. Not yet. This time, we planned a study to investigate the occurrence and severity of symptoms one week after the test.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Regarding incidental events related to upper gastrointestinal X-ray examination, whether or not they have occurred one week after the examination.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Those who underwent a complete medical checkup or stomach X-ray examination for gastric cancer screening

Key exclusion criteria

Persons who cannot consent to participate in research

Target sample size

5000


Research contact person

Name of lead principal investigator

1st name TSUNEYA
Middle name
Last name WADA

Organization

Okazaki Medical Association

Division name

Harusaki Medical Center

Zip code

4440875

Address

1-9-1 Tatsumi-nishi Okazaki Aichi

TEL

0564521572

Email

t-wada@okazaki-med.or.jp


Public contact

Name of contact person

1st name TSUNEYA
Middle name
Last name WADA

Organization

Okazaki Medical Association

Division name

Harusaki Medical Center

Zip code

4440875

Address

1-9-1 Tatsumi-nishi Okazaki Aichi

TEL

0564521572

Homepage URL


Email

t-wada@okazaki-med.or.jp


Sponsor or person

Institute

Okazaki Medical Association

Institute

Department

Personal name



Funding Source

Organization

Okazaki Medical Association

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagoya City University Hospital

Address

1 Kawasumi Mizuho Nagoya Aichi

Tel

052-858-7215

Email

irb_jimu@med.nagoya-cu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2024 Year 01 Month 01 Day

Date of IRB

2023 Year 12 Month 18 Day

Anticipated trial start date

2024 Year 01 Month 01 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

(Explanation of research content)
After the gastric X-ray examination is completed, the researcher will explain about participating in the questionnaire survey in the examination room.
(Observation of subjective symptoms and answering questionnaires)
Research subjects were observed after returning home, and the subjects were checked for "5.5.4 Observation and Test Items" such as their physical condition before the test, the number of times they took laxatives after the test, the number of days until barium stool was excreted, and their subjective symptoms up to one week later. After answering the questionnaire regarding the contents, mail it to the research office using a return envelope.


Management information

Registered date

2024 Year 06 Month 06 Day

Last modified on

2024 Year 06 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062381